Literature DB >> 7193307

Absorption of levodopa after rectal administration.

T Eisler, N Eng, C Plotkin, D B Calne.   

Abstract

Absorption of levodopa was studied after administration by mouth and rectum. Given by mouth, levodopa benefited all 12 patients studied, and levodopa blood levels rose significantly (p less than 0.01). When it was given rectally, there was no rise in levodopa concentration in the blood and no clinical benefit. Rectally administered levodopa is therefore of no value in the management of postoperative parkinsonian patients who cannot take oral medication.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7193307     DOI: 10.1212/wnl.31.2.215

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  12 in total

1.  Case report: successful use of rectally administered levodopa-carbidopa.

Authors:  S D Cooper; H A Ismail; C Frank
Journal:  Can Fam Physician       Date:  2001-01       Impact factor: 3.275

Review 2.  Old Drugs, New Delivery Systems in Parkinson's Disease.

Authors:  Harsh V Gupta; Kelly E Lyons; Rajesh Pahwa
Journal:  Drugs Aging       Date:  2019-09       Impact factor: 3.923

Review 3.  Clinical pharmacokinetics of anti-parkinsonian drugs.

Authors:  J M Cedarbaum
Journal:  Clin Pharmacokinet       Date:  1987-09       Impact factor: 6.447

4.  Stability of Levodopa/Carbidopa Rectal Suspensions.

Authors:  Ronald F Donnelly
Journal:  Hosp Pharm       Date:  2016-12

Review 5.  [Parkinson's disease. Perioperative management and anesthesia].

Authors:  U Wüllner; J Standop; O Kaut; V Coenen; A Kalenka; F Wappler
Journal:  Anaesthesist       Date:  2012-02       Impact factor: 1.041

6.  The influence of net water absorption on the permeability of antipyrine and levodopa in the human jejunum.

Authors:  D Nilsson; U Fagerholm; H Lennernäs
Journal:  Pharm Res       Date:  1994-11       Impact factor: 4.200

Review 7.  Rectal drug administration: clinical pharmacokinetic considerations.

Authors:  A G de Boer; F Moolenaar; L G de Leede; D D Breimer
Journal:  Clin Pharmacokinet       Date:  1982 Jul-Aug       Impact factor: 6.447

Review 8.  Anti-parkinsonian drugs today.

Authors:  N P Quinn
Journal:  Drugs       Date:  1984-09       Impact factor: 9.546

9.  The effect of L-leucine on the absorption of levodopa, studied by regional jejunal perfusion in man.

Authors:  H Lennernäs; D Nilsson; S M Aquilonius; O Ahrenstedt; L Knutson; L K Paalzow
Journal:  Br J Clin Pharmacol       Date:  1993-03       Impact factor: 4.335

Review 10.  Pharmacokinetic optimisation in the treatment of Parkinson's disease : an update.

Authors:  Dag Nyholm
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 5.577

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.